Lymphatic system and tissue macrophages

The lymphatic system and tissue macrophages collectively represent a critical component of the body's immune and fluid management infrastructure (StatPearls, 2023). The lymphatic system consists of a network of vessels, nodes, and organs that maintain fluid balance and facilitate the transport of immune cells and lipids (NIH, 2022). Tissue macrophages, part of the mononuclear phagocyte system (MPS), are resident immune cells responsible for phagocytosis, antigen presentation, and tissue homeostasis (Nature Reviews Immunology, 2014). In pharmacology, this 'target' is often viewed as a site for drug delivery, such as vaccines or nanomedicines, or as a clearance mechanism for particulate drug carriers (Journal of Controlled Release, 2019). While not a single molecular receptor, its role in cancer metastasis and inflammatory diseases makes it a focal point for therapeutic intervention and diagnostic imaging (PubMed, 2021). Macrophages within the lymph nodes are particularly important for capturing antigens and initiating adaptive immune responses. Therapeutic strategies often aim to either bypass these cells to increase drug half-life or specifically target them to modulate immune activity. Understanding the interaction between drug delivery systems and these biological components is essential for optimizing efficacy and minimizing off-target effects.

Other names

Reticuloendothelial systemMononuclear phagocyte systemMPSRESLymphatic network

Drugs targeting this system typically utilize mannose receptor binding, phagocytic uptake, or passive lymphatic drainage to achieve localization or clearance.